white bio
Scope
Date
~
-
Bio & Pharma
Orion enters China’s vaccine market with tuberculosis plant in Jining
Orion Holdings Corp., one of South Korea’s largest confectionery companies, said on Wednesday it will build a vaccine plant in China by 2024 t...
Jul 13, 2022 (Gmt+09:00)
language -
Bio & Pharma
Korean biotech L&C Bio issues convertible bonds worth $46 mn
South Korean biotech company L&C Bio, which specializes in tissue regeneration treatment, is poised to ramp up its expansion into the Chinese ma...
Jun 30, 2022 (Gmt+09:00)
language -
Bio & Pharma
Lotte plans to expand bio capacity in Korea and US
Lotte Group is preparing to kickstart its biopharmaceutical business as a contract development and manufacturing company (CDMO) by building a new pl...
Jun 16, 2022 (Gmt+09:00)
language -
Tech, Media & Telecom
Disney+ becomes white elephant for LG Uplus
For South Korea’s wireless carrier LG Uplus, Disney+ may have become more trouble than it is worth.The country’s video-on-demand over-th...
Jun 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms flock to US as SV Invest eyes $100 million bio fund
SV Investment, a South Korean venture capital and private equity firm, is looking to launch a $100 million bio fund in the US as a growing number of...
Jun 13, 2022 (Gmt+09:00)
language -
Behind the Scenes
Samsung in do-or-die race with $355 bn spending plan
"It's not a matter of numbers, but a matter of do or die for us."This is the first public remark from Samsung Electronics Co. Vice Chairman and de f...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
SK takes aim at chips, batteries, bio with $195 billion investment
SK Group, South Korea’s second-largest conglomerate after Samsung, on Thursday announced a plan to invest 247 trillion won ($195 billion) in k...
May 26, 2022 (Gmt+09:00)
language -
Corporate investment
Bio, mobility to top Lotte's $30 bn spending list by 2026
South Korea’s Lotte Group will spend a total of 37 trillion won ($29 billion) on its businesses over the next five years, a chunk of which wil...
May 25, 2022 (Gmt+09:00)
language -
Corporate investment
Samsung to invest $355 billion in chip, biotech, 6G over five years
South Korea’s top conglomerate Samsung has unveiled a plan to invest 450 trillion won ($355 billion) over the next five years in strategic sec...
May 24, 2022 (Gmt+09:00)
language -
Carbon neutrality
Hyundai Oilbank steps up eco-friendly white bio business
Hyundai Oilbank Co., a South Korean petroleum and refinery company, is slated to tap into the white biotechnology market. The company has selected w...
May 11, 2022 (Gmt+09:00)
-
Pension funds
POBA targets PE in tech, bio, healthcare in long term, CIO says
Public Officials Benefit Association (POBA) of South Korea will keep its focus on steady cash flow while strengthening profitability, its Chief Inve...
May 09, 2022 (Gmt+09:00)
-
IPOs
Korea’s tough IPO review drives bio startup to Nasdaq
A South Korean bio startup is aiming for a Nasdaq listing, deeming that the country’s exchange sets the bar too high for an initial public off...
Apr 22, 2022 (Gmt+09:00)
-
Shareholder activism
Naver emerges as Hanjin KAL’s white knight with stake purchase
South Korea’s online portal giant Naver Corp. has emerged as one of Hanjin KAL Co.'s key friendly shareholders, throwing its clout behind Chai...
Apr 17, 2022 (Gmt+09:00)
-
Real estate
Warehouses pile financial burden on investment firms
South Korea’s logistics centers are ramping up the financial pressure on real estate investment firms. Previously a favored property type, i...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
IPOs
Korean IPOs delayed after bourse's sweeping reshuffle
Scores of South Korean initial public offerings slated for the first half of this year have been delayed after the bourse operator carried out a lar...
Mar 17, 2022 (Gmt+09:00)
-
Private equity
Korean SPAC Valuence Merger debuts on Nasdaq, targets bio M&As
Valuence Merger Corp. 1, a special purpose acquisition company (SPAC), led by South Korean fund managers, has debuted on the Nasdaq, targeting Asian...
Mar 04, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio ventures struggle with fundraising
Biopharmaceutical companies of South Korea are having a tough time fundraising of late. Bio ventures without specific public offering plans are pa...
Mar 01, 2022 (Gmt+09:00)
-
Business & Politics
LG recruits former WH deputy chief of staff Joe Hagin for govt relations
LG Corp. announced on Sunday that the group has recruited former White House deputy chief of staff Joe Hagin for its Washington D.C. office. Ha...
Feb 21, 2022 (Gmt+09:00)
-
Corporate restructuring
SK's 5-year journey toward batteries, bio and chips
Back in January 2017, SK Group Chairman Chey Tae-won emphasized the need for “deep change," in his New Year message and presented the phrase a...
Jan 23, 2022 (Gmt+09:00)
-
Pharmaceuticals
ABL Bio in $1.06 bn deal with Sanofi for Parkinson's disease treatment
South Korea’s ABL Bio Inc. has signed a $1.06 billion contract to license out its technology for a Parkinson's disease treatment candidate t...
Jan 12, 2022 (Gmt+09:00)
-
Private equity
CICC to form up to $3.3 bn funds for bio, chips in Korea and others
CICC Capital, a private equity firm of China's largest investment bank China International Capital Corporation (CICC), will create funds with a comb...
Jan 10, 2022 (Gmt+09:00)
language -
COVID-19
SK Bioscience to sell Novavax COVID-19 vaccine in Thailand, Vietnam
SK Bioscience Co., a biopharmaceutical unit of South Korea’s SK Group, said on Friday it has acquired non-exclusive rights to sell US-based No...
Dec 24, 2021 (Gmt+09:00)
language -
Economy
Korea exports hit record to top $640 bn in 2021
South Korea’s exports have reached an all-time high thanks to strong overseas demand for key products such as semiconductors amid the global e...
Dec 14, 2021 (Gmt+09:00)
language -
Business & Politics
Samsung likely to announce US foundry investment plan this week
Samsung Electronics Co. is expected to announce an investment plan for its second US-based semiconductor foundry plant this week. As the South Kor...
Nov 22, 2021 (Gmt+09:00)
language -
Bio
K-bio's out-licensing this year reaches $9.3 bn
Overseas technology transfers from South Korean biotechs and pharmaceutical manufacturers this year have exceeded 11 trillion won ($9.3 billion), al...
Nov 18, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
CJ Cheiljedang to acquire Dutch bio firm Batavia for 195 million euros
CJ Cheiljedang Corp., a key subsidiary of South Korea’s food and entertainment conglomerate CJ Group, said on Monday it is acquiring Batavia B...
Nov 08, 2021 (Gmt+09:00)
-
Bio
Sartorius to invest $300 mn in bio material, equipment plant in Korea
Sartorius AG, German laboratory equipment and raw material maker, is slated to invest $300 million in the next three years to build a plant in South...
Nov 03, 2021 (Gmt+09:00)
language -
Shareholder activism
SK Chem says no immediate plan to sell SK Bioscience stake
SK Chemicals Co., the top shareholder of South Korea's SK Bioscience Co., is not considering reducing its stake in the vaccine maker in the immediat...
Nov 02, 2021 (Gmt+09:00)
-
Korean startups
Portrai to revolutionize biopsy quality through AI technology
Biopsy is one of the most used methods to examine a person’s illness, taking a tissue sample of a patient for analysis. Usually, the samples a...
Oct 06, 2021 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand